Literature DB >> 22339232

APOBEC2 is a monomer in solution: implications for APOBEC3G models.

Troy C Krzysiak1, Jinwon Jung, James Thompson, David Baker, Angela M Gronenborn.   

Abstract

Although the physiological role of APOBEC2 is still largely unknown, a crystal structure of a truncated variant of this protein was determined several years ago [Prochnow, C. (2007) Nature445, 447-451]. This APOBEC2 structure had considerable impact in the HIV field because it was considered a good model for the structure of APOBEC3G, an important HIV restriction factor that abrogates HIV infectivity in the absence of the viral accessory protein Vif. The quaternary structure and the arrangement of the monomers of APOBEC2 in the crystal were taken as being representative for APOBEC3G and exploited in explaining its enzymatic and anti-HIV activity. Here we show, unambiguously, that in contrast to the findings for the crystal, APOBEC2 is monomeric in solution. The nuclear magnetic resonance solution structure of full-length APOBEC2 reveals that the N-terminal tail that was removed for crystallization resides close to strand β2, the dimer interface in the crystal structure, and shields this region of the protein from engaging in intermolecular contacts. In addition, the presence of the N-terminal region drastically alters the aggregation propensity of APOBEC2, rendering the full-length protein highly soluble and not prone to precipitation. In summary, our results cast doubt on all previous structure-function predictions for APOBEC3G that were based on the crystal structure of APOBEC2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22339232      PMCID: PMC3316327          DOI: 10.1021/bi300021s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  61 in total

1.  APOBEC3 proteins inhibit human LINE-1 retrotransposition.

Authors:  Heide Muckenfuss; Matthias Hamdorf; Ulrike Held; Mario Perkovic; Johannes Löwer; Klaus Cichutek; Egbert Flory; Gerald G Schumann; Carsten Münk
Journal:  J Biol Chem       Date:  2006-05-30       Impact factor: 5.157

2.  Crystal structures of blasticidin S deaminase (BSD): implications for dynamic properties of catalytic zinc.

Authors:  Takashi Kumasaka; Masaki Yamamoto; Makio Furuichi; Masayoshi Nakasako; Aik-Hong Teh; Makoto Kimura; Isamu Yamaguchi; Tatzuo Ueki
Journal:  J Biol Chem       Date:  2007-10-23       Impact factor: 5.157

3.  Extensive mutagenesis experiments corroborate a structural model for the DNA deaminase domain of APOBEC3G.

Authors:  Kuan-Ming Chen; Natalia Martemyanova; Yongjian Lu; Keisuke Shindo; Hiroshi Matsuo; Reuben S Harris
Journal:  FEBS Lett       Date:  2007-09-07       Impact factor: 4.124

4.  The 1.48 A resolution crystal structure of the homotetrameric cytidine deaminase from mouse.

Authors:  Aik-Hong Teh; Makoto Kimura; Masaki Yamamoto; Nobuo Tanaka; Isamu Yamaguchi; Takashi Kumasaka
Journal:  Biochemistry       Date:  2006-06-27       Impact factor: 3.162

5.  The APOBEC-2 crystal structure and functional implications for the deaminase AID.

Authors:  Courtney Prochnow; Ronda Bransteitter; Michael G Klein; Myron F Goodman; Xiaojiang S Chen
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

6.  Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.

Authors:  Kuan-Ming Chen; Elena Harjes; Phillip J Gross; Amr Fahmy; Yongjian Lu; Keisuke Shindo; Reuben S Harris; Hiroshi Matsuo
Journal:  Nature       Date:  2008-02-20       Impact factor: 49.962

7.  Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.

Authors:  Heather L Wiegand; Bryan R Cullen
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

8.  Cyclical DNA methylation of a transcriptionally active promoter.

Authors:  Raphaël Métivier; Rozenn Gallais; Christophe Tiffoche; Christine Le Péron; Renata Z Jurkowska; Richard P Carmouche; David Ibberson; Peter Barath; Florence Demay; George Reid; Vladimir Benes; Albert Jeltsch; Frank Gannon; Gilles Salbert
Journal:  Nature       Date:  2008-03-06       Impact factor: 49.962

9.  Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.

Authors:  Thomas F Baumert; Christine Rösler; Michael H Malim; Fritz von Weizsäcker
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

10.  Model structure of human APOBEC3G.

Authors:  Kun-Lin Zhang; Bastien Mangeat; Millan Ortiz; Vincent Zoete; Didier Trono; Amalio Telenti; Olivier Michielin
Journal:  PLoS One       Date:  2007-04-18       Impact factor: 3.240

View more
  23 in total

Review 1.  Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.

Authors:  Belete A Desimmie; Krista A Delviks-Frankenberrry; Ryan C Burdick; DongFei Qi; Taisuke Izumi; Vinay K Pathak
Journal:  J Mol Biol       Date:  2013-11-02       Impact factor: 5.469

2.  The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.

Authors:  Shingo Kitamura; Hirotaka Ode; Masaaki Nakashima; Mayumi Imahashi; Yuriko Naganawa; Teppei Kurosawa; Yoshiyuki Yokomaku; Takashi Yamane; Nobuhisa Watanabe; Atsuo Suzuki; Wataru Sugiura; Yasumasa Iwatani
Journal:  Nat Struct Mol Biol       Date:  2012-09-23       Impact factor: 15.369

3.  Functional requirements of AID's higher order structures and their interaction with RNA-binding proteins.

Authors:  Samiran Mondal; Nasim A Begum; Wenjun Hu; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

4.  Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability.

Authors:  Yuqing Feng; Robin P Love; Anjuman Ara; Tayyba T Baig; Madison B Adolph; Linda Chelico
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

5.  An Insulin-Responsive Sensor in the SIRT1 Disordered Region Binds DBC1 and PACS-2 to Control Enzyme Activity.

Authors:  Troy C Krzysiak; Laurel Thomas; You-Jin Choi; Sylvain Auclair; Yiqi Qian; Shan Luan; Stephanie M Krasnow; Laura L Thomas; Leonardus M I Koharudin; Panayiotis V Benos; Daniel L Marks; Angela M Gronenborn; Gary Thomas
Journal:  Mol Cell       Date:  2018-11-08       Impact factor: 17.970

6.  Structural and functional assessment of APOBEC3G macromolecular complexes.

Authors:  Bogdan Polevoda; William M McDougall; Ryan P Bennett; Jason D Salter; Harold C Smith
Journal:  Methods       Date:  2016-03-14       Impact factor: 3.608

7.  APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

Authors:  Jinhui Li; Yan Chen; Ming Li; Michael A Carpenter; Rebecca M McDougle; Elizabeth M Luengas; Patrick J Macdonald; Reuben S Harris; Joachim D Mueller
Journal:  J Mol Biol       Date:  2013-12-17       Impact factor: 5.469

8.  Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.

Authors:  Ke Shi; Michael A Carpenter; Kayo Kurahashi; Reuben S Harris; Hideki Aihara
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

Review 9.  The APOBEC Protein Family: United by Structure, Divergent in Function.

Authors:  Jason D Salter; Ryan P Bennett; Harold C Smith
Journal:  Trends Biochem Sci       Date:  2016-06-06       Impact factor: 13.807

10.  Zinc-binding domain-dependent, deaminase-independent actions of apolipoprotein B mRNA-editing enzyme, catalytic polypeptide 2 (Apobec2), mediate its effect on zebrafish retina regeneration.

Authors:  Curtis Powell; Eli Cornblath; Daniel Goldman
Journal:  J Biol Chem       Date:  2014-09-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.